At a glance
- Originator Fidia Farmaceutici
- Class Antiepileptic drugs; Anxiolytics; Neuroprotectants
- Mechanism of Action GABA A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Anxiety disorders; Epilepsy
Most Recent Events
- 07 Jun 2001 Discontinued-Unspecified phase in Anxiety disorders in USA (Unknown route)
- 07 Jun 2001 Discontinued-Unspecified phase in Epilepsy in USA (Unknown route)
- 29 Jan 1997 No-Development-Reported for Anxiety disorders in USA (Unknown route)